$27.88
-0.52-1.83%
Last update: Nov 5, 4:00 PM

The average analyst price target for RXO is $27.92, 0.1% above the current price. Of 14 analysts, 5 rate it Buy and 9 Hold. Targets range from $15 to $35. The latest change came on Nov 4, 2026, when UBS raised its price target on RXO from $23 to $30.25 and kept a Neutral rating.
Price Target Range — 10 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months